Aptamer Group announced on Tuesday that it has signed a new contract worth up to £0.62m with a top five global pharmaceutical ...

Aptamer Group Plc ( ($GB:APTA) ) has provided an update. Aptamer Group has secured a significant new contract with a top five pharmaceutical ...

At times, aging doesn’t become evident in wrinkles or in gray hair, it occurs deep inside your body, in cells that have ceased to divide but are still alive. These “zombie cells,” or senescent cells ...

Aptamer Group, which develops next-generation synthetic binders for the life sciences industry, has secured a new contract ...

Mayo Clinic researchers report finding a new technique to tag senescent cells. The team used molecules known as "aptamers" — ...

The new £360,000 fee-for-service development contract is to develop Optimer® binders as targeted radiopharmaceuticals with ...

Aptamer Group Ltd., the developer of Optimer® binders to enable innovation in the life science industry, is pleased to announce the expansion of its existing partnership with DeepVerge PLC. This will ...

The gold-standard method for detecting viruses is based on reverse transcription polymerase chain reaction (RT-PCR). But this tends to be time-consuming and expensive, and its high sensitivity can ...

Generating specific cell lineages from induced pluripotent stem cells and embryonic stem cells is the holy grail of regenerative medicine. Guiding iPSCs toward a target cell line has garnered much ...

CAGE Bio Inc., a clinical-stage biotechnology company pioneering novel immunomodulatory therapies for dermatological diseases ...